Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study
Completed · Not applicable
Conditions studied: Cystic Fibrosis
In brief
STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this population.
Key facts
- Study ID
- NCT04608019
- Run by
- University of Washington, the Collaborative Health Studies Coordinating Center
- People needed
- 121
- Starts
- 2020-11-10
- Expected to finish
- 2022-08-18
- Last updated by the study team
- 2024-10-18
Who can join
Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Tucson Cystic Fibrosis Center — Tucson, Arizona, United States
- Children's Hospital of Colorado — Aurora, Colorado, United States
- Children's Healthcare of Atlanta — Atlanta, Georgia, United States
- Lurie Children's Hospital of Chicago & Northwestern University — Chicago, Illinois, United States
- Riley Hospital for Children — Indianapolis, Indiana, United States
- Helen DeVos Children's Hospital — Grand Rapids, Michigan, United States
- Oregon Health Sciences University — Portland, Oregon, United States
- Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States
- Texas Children's Hospital and Baylor College of Medicine — Houston, Texas, United States
- Seattle Children's Hospital — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.